Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.

Journal of virology - 1 Sept 2001

Henke A, Zell R, Ehrlich G, Stelzner A

Abstract excerpt

Clinical and laboratory investigations have demonstrated the involvement of viruses and bacteria as potential causative agents in cardiovascular disease and have specifically found coxsackievirus B3 (CVB3) to be a leading cause. Experimental data indicate that cytokines are involved in controlling CVB3 replication. Therefore, recombinant CVB3 (CVB3rec) variants expressing the T-helper-1 (T(H)1)-specific gamma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coxsackievirus Infections
Share to Enterovirus B, Human

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Interferon-gamma

Share to Interleukin-10

Share to Mice, Inbred BALB C

Share to Myocarditis

Share to Pancreas

Source

Open in PubMed Open full text

Identifiers

PMID: 11483764
DOI: 10.1128/jvi.75.17.8187-8194.2001
PMCID: PMC115063

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.PMID 11483764Read ↗

Attenuated strain of CVB3 with a mutation in the CAR-interacting region protects against both myocarditis and pancreatitis.Semantic proximity Read ↗

Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis.Semantic proximity Read ↗

The role of B cells in regulation of Th cell differentiation in Coxsackievirus B3-Induced Acute MyocarditisSemantic proximity Read ↗

A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection.Semantic proximity Read ↗

Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis.Semantic proximity Read ↗

Neutralizing activity induced by the attenuated coxsackievirus B3 Sabin3-like strain against CVB3 infection.Semantic proximity Read ↗

Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines.Semantic proximity Read ↗

A non-cardiovirulent strain of coxsackievirus B3 causes myocarditis in mice with severe combined immunodeficiency syndrome.Semantic proximity Read ↗

Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate.Semantic proximity Read ↗

The Severity of CVB3-Induced Myocarditis Can Be Improved by Blocking the Orchestration of NLRP3 and Th17 in Balb/c Mice.Semantic proximity Read ↗

An attenuated variant of Coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo.Semantic proximity Read ↗

A Self-Assembled Viral Protein VP1 Induces Protective Immunity Against Coxsackievirus B3 (CVB3) Lethal Challenges in Balb/c Mice ModelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.